Chronic allograft nephropathy: An update

被引:328
|
作者
Paul, LC [1 ]
机构
[1] Leiden Univ, Ctr Med, Dept Nephrol, NL-2300 RC Leiden, Netherlands
关键词
renal transplantation; transplant failure; immune-lymphatic theory; cytokines; graft injury;
D O I
10.1046/j.1523-1755.1999.00611.x
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Chronic allograft nephropathy is the most prevalent cause of renal transplant failure in the first post-transplant decade, but its pathogenesis has remained elusive. Clinically, it is characterized by a slow but variable loss of function, often in combination with proteinuria and hypertension. The histopathology is also not specific, but transplant glomerulopathy and multilayering of the peritubular capillaries are highly characteristic. Several risk factors have been identified, such as advanced donor age, delayed graft function, repeated acute rejection episodes, vascular rejection episodes, and rejections that occur late after transplantation. A common feature of chronic allograft nephropathy is that it develops in grafts that have undergone previous damage, although the mechanism(s) responsible for the progressive fibrosis and tissue remodeling has not yet been defined. Hypotheses to explain chronic allograft nephropathy include the immunolymphatic theory, the cytokine excess theory, the loss of supporting architecture theory, and the premature senescence theory. The most effective option to prevent chronic allograft nephropathy is to avoid graft injury from both immune and nonimmune mechanisms.
引用
收藏
页码:783 / 793
页数:11
相关论文
共 50 条
  • [41] An update on chronic lung allograft dysfunction
    Kotecha, Sakhee
    Paraskeva, Miranda A.
    Levin, Kovi
    Snell, Gregory I.
    ANNALS OF TRANSLATIONAL MEDICINE, 2020, 8 (06)
  • [42] Urinary proteomic analysis of chronic allograft nephropathy
    O'Riordan, Edmond
    Orlova, Tatyana N.
    Mendelev, Natalia
    Patschan, Daniel
    Kemp, Rowena
    Chander, Praveen N.
    Hu, Rena
    Hao, Gang
    Gross, Steven S.
    Iozzo, Renato V.
    Delaney, Veronica
    Goligorsky, Michael S.
    PROTEOMICS CLINICAL APPLICATIONS, 2008, 2 (7-8) : 1025 - 1035
  • [43] Is it time for ACE inhibitors in chronic allograft nephropathy?
    Lewis, JB
    Helderman, JH
    AMERICAN JOURNAL OF KIDNEY DISEASES, 2000, 35 (01) : 154 - 156
  • [44] Acute rejections and chronic allograft nephropathy.
    Qvist, E
    Their, M
    Krogerus, L
    Holmberg, C
    Jalanko, H
    PEDIATRIC TRANSPLANTATION, 2005, 9 : 58 - 58
  • [45] Efficacy of Sirolimus in Children with Chronic Allograft Nephropathy
    Seeman, T.
    Podracka, L.
    PEDIATRIC NEPHROLOGY, 2010, 25 (09) : 1895 - 1895
  • [46] Prevention of chronic allograft nephropathy with vitamin D
    Hullett, DA
    Laeseke, PF
    Malin, G
    Nessel, R
    Sollinger, HW
    Becker, BN
    TRANSPLANT INTERNATIONAL, 2005, 18 (10) : 1175 - 1186
  • [47] Protocol biopsies as predictors of chronic allograft nephropathy
    Seron, D
    TRANSPLANTATION PROCEEDINGS, 2003, 35 (06) : 2131 - 2132
  • [48] A novel approach to the treatment of chronic allograft nephropathy
    Weir, MR
    Anderson, L
    Fink, JC
    Gabregiorgish, K
    Schweitzer, EJ
    Hoehn-Saric, E
    Klassen, DK
    Cangro, CB
    Johnson, LB
    Kuo, PC
    Lim, JY
    Bartlett, ST
    TRANSPLANTATION, 1997, 64 (12) : 1706 - 1710
  • [49] Chronic allograft nephropathy -: biopsy findings and outcome
    Freese, P
    Svalander, CT
    Mölne, J
    Nordén, G
    Nyberg, G
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2001, 16 (12) : 2401 - 2406
  • [50] The role of replicative senescence in chronic allograft nephropathy
    Ferlicot, S
    Durrbach, A
    Bâ, N
    Desvaux, D
    Bedossa, P
    Paradis, V
    HUMAN PATHOLOGY, 2003, 34 (09) : 924 - 928